ALB and familial dilated cardiomyopathy: In contrast to the participants in group 3 (S′>11 cm/s), there was a significant increased risk of outcome with participants in group 1 (S′<10 cm/s; OR, 2.90; 95% CI, 1.33–6.31) alongside patients in group 2 (S′: 10–11 cm/s; OR, 2.18; 95% CI, 1.10–4.33; p for trend = 0.006) after the full adjustment for potential confounders that include age, sex, first admission, NYHA class IV, hypertension, DCM, A fib/A flutter, serum sodium, serum albumin, SBP, β-blockers, LVEF, LV EDD, RA diameter, and RV diameter.